
Paramount Peptides
Tirzepatide
Finnrick tested 6 samples of Tirzepatide (GLP-1 and GIP antagonist) from Paramount Peptides between 14 Jan 2025 and 20 Mar 2025. Tests score average over 4, no score below 3, and at least 6 tests warrant a confident Finnrick Rating of D (Poor).
Finnrick Rating™
Paramount Peptides
Tirzepatide
Tested 6 Samples
Last test 20 Mar 2025
Take Action
Mail in a Sample
We test your peptides for free: mail in a sample you have (US only), or request us to test a vendor.
Tirzepatide is also available from top-rated vendors:
All Tirzepatide tests from Paramount Peptides
Samples are tested in commercial labs
Tests Count
6
Scores
AVGMINMAX
Last
20 Mar 2025
First
14 Jan 2025
Quantity | |||||||||
---|---|---|---|---|---|---|---|---|---|
Test Date | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
20 Mar 2025 | 10mg | 11.700mg | +17.0% | 99.97% | TIR10n01162025 | Blue Label / Clear Cap | Lab B | Finnrick | |
28 Feb 2025 | 10mg | 11.197mg | +12.0% | 99.76% | TIR10n01162025 | Blue Label / Clear Cap | Lab C | Finnrick | |
28 Feb 2025 | 10mg | 11.144mg | +11.4% | 99.94% | TIR10n01162025 | Blue Label / Clear Cap | Lab C | Finnrick | |
27 Feb 2025 | 10mg | 11.710mg | +17.1% | 99.32% | TIR10n01162025 | Blue Label / Clear Cap | Lab A | Finnrick | |
23 Jan 2025 | 10mg | 11.680mg | +16.8% | 99.08% | (no batch ID) | (no data) | Lab B | Finnrick | |
14 Jan 2025 | 10mg | 10.950mg | +9.5% | 98.91% | (no batch ID) | (no data) | Lab A | Finnrick |